Last updated:
Author(s):
Emerging Risk Factors Collaboration/EPIC-CVD/Vitamin D Studies Collaboration.
Publish date:
1 December 2021
Journal:
Lancet Diabetes Endocrinol
PubMed ID:
34717822
DOI:
10.1016/S2213-8587(21)00263-1

Related projects

Vitamin D pathway and major disease outcomes: Observational associations and causal inference by Mendelian randomisation.

Lower circulating levels of 25-hydroxyvitamin D [25(OH)D], the principal clinical biomarker of vitamin D status, have been associated with increased risk of many disease outcomes,…

Institution:
University of Cambridge, Great Britain

All projects